Michael L. Levitz
2021 - Anika Therapeutics
In 2021, Michael L. Levitz earned a total compensation of $1.6M as EVP, Chief Financial Officer and Treasurer at Anika Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $205,362 |
|---|---|
| Option Awards | $453,004 |
| Salary | $456,400 |
| Stock Awards | $452,710 |
| Other | $21,380 |
| Total | $1,588,856 |
Levitz received $456.4K in salary, accounting for 29% of the total pay in 2021.
Levitz also received $205.4K in bonus, $453K in option awards, $452.7K in stock awards and $21.4K in other compensation.
Rankings
In 2021, Michael L. Levitz's compensation ranked 7,008th out of 12,404 executives tracked by ExecPay. In other words, Levitz earned more than 43.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,008 out of 12,404 | 44th |
Division Manufacturing | 3,069 out of 5,494 | 44th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 404 out of 798 | 49th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 255 out of 519 | 51st |
Industry Surgical and Medical Instruments and Apparatus | 163 out of 324 | 50th |
Source: SEC filing on April 27, 2022.
Levitz's colleagues
We found four more compensation records of executives who worked with Michael L. Levitz at Anika Therapeutics in 2021.